Quick Takeaways
- Vivo Opportunity Fund Holdings, L.P. filed SCHEDULE 13G for Bright Minds Biosciences Inc. Common Stock, no par value (DRUG).
- Disclosed ownership: 6.4%.
- Date of event: 30 Sep 2025.
Vivo Opportunity Fund Holdings, L.P. - 30 Sep 2025 SCHEDULE 13G Report for Bright Minds Biosciences Inc. Common Stock, no par value (DRUG)
- Filing Manager
- Vivo Opportunity Fund Holdings, L.P.
- Reporting Manager
- Vivo Opportunity Fund Holdings, L.P.
- Symbol
- DRUG
- Shares outstanding
- 7,096,625 shares
- Disclosed Ownership
- 454,184 shares
- Ownership
- 6.4%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Nov 2025, 18:38:08 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Vivo Opportunity Fund Holdings, L.P. disclosed 6.4% ownership in Bright Minds Biosciences Inc. Common Stock, no par value (DRUG) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 18:38.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 6.4% | 454,184 | 454,184 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner | |
| Vivo Opportunity, LLC | 6.4% | 454,184 | 454,184 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member | |
| Vivo Opportunity Cayman Fund, L.P. | 0.7% | 47,433 | 47,433 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner | |
| Vivo Opportunity Cayman, LLC | 0.7% | 47,433 | 47,433 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member |